CHELSEA FOSTER: Open Payments
NPI 1982144150 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 6 payments from 4 companies in 2025. Trend: 2023 $438 · 2024 $348 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| AVYXA PHARMA, LLC | 1 | $132 |
| Genmab U.S., Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $73 |
| PUMA BIOTECHNOLOGY, INC. | 3 | $63 |
Products named: LUTRATE DEPOT, Epkinly, ZENPEP, NERLYNX.
Industry payments across MI — which companies pay providers there.
